New approach to shutting down breast cancer recurrence shows promise in mice

by Sarah Avery,Duke UniversityGraphical Abstract. Credit:Cell Reports(2019). DOI: 10.1016/j.celrep.2019.09.032A new approach to treat advanced breast cancer shuts down the growth of

Updated on: March 12,2024

New approach to shutting down breast cancer recurrence shows promise in mice

by Sarah Avery,Duke UniversityGraphical Abstract. Credit:Cell Reports(2019). DOI: 10.1016/j.celrep.2019.09.032A new approach to treat advanced breast cancer shuts down the growth of

Updated on:March 12,2024

Antitumor cell activity in glioblastoma regulated by inhibiting triggering receptor expressed on myeloid cells 2

by Thamarasee Jeewandara , Medical XpressTREM2 expression is higher in GBM tumors than normal brain tissue and inversely correlates with patient outcome. (A) Box plots of TREM2 expression in IDH1/2–wi

Updated on: February 24,2024

Antitumor cell activity in glioblastoma regulated by inhibiting triggering receptor expressed on myeloid cells 2

by Thamarasee Jeewandara , Medical XpressTREM2 expression is higher in GBM tumors than normal brain tissue and inversely correlates with patient outcome. (A) Box plots of TREM2 expression in IDH1/2–wi

Updated on:February 24,2024

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

Updated on: January 15,2024

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

Updated on:January 15,2024

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on: March 30,2024

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on:March 30,2024

Study: Involving hospitalists in inpatient cancer care reduces patient stays, oncologist stress

by Yale UniversityCredit: CC0 Public DomainInvolving hospitalists in the co-management of care for patients with cancer is associated with decreased length of hospital stay for patients, increase

Updated on: February 03,2024

Study: Involving hospitalists in inpatient cancer care reduces patient stays, oncologist stress

by Yale UniversityCredit: CC0 Public DomainInvolving hospitalists in the co-management of care for patients with cancer is associated with decreased length of hospital stay for patients, increase

Updated on:February 03,2024

Study reinforces potential use of zika virus to combat prostate cancer but points to possible side-effect

by Julia Moióli,FAPESPAbstract. Credit:Journal of Proteome Research(2022). DOI: 10.1021/acs.jproteome.2c00630Preclinical trials have shown that zika virus can inhibit the spread of p

Updated on: January 28,2024

Study reinforces potential use of zika virus to combat prostate cancer but points to possible side-effect

by Julia Moióli,FAPESPAbstract. Credit:Journal of Proteome Research(2022). DOI: 10.1021/acs.jproteome.2c00630Preclinical trials have shown that zika virus can inhibit the spread of p

Updated on:January 28,2024

Artificial intelligence analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of the proteins

Updated on: April 30,2024

Artificial intelligence analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainA blood-based machine learning assay that combines cell-free DNA (cfDNA) fragment patterns and levels of the proteins

Updated on:April 30,2024

Unique genetic signature found by research in different types of cancer

by MELISA InstitutetimsTOF Pro mass spectrometer located in MELISA Institute's laboratories. Credit: MELISA InstituteResearch led by Dr. Mabel Vidal in the Department of Computer Science at the Un

Updated on: January 07,2024

Unique genetic signature found by research in different types of cancer

by MELISA InstitutetimsTOF Pro mass spectrometer located in MELISA Institute's laboratories. Credit: MELISA InstituteResearch led by Dr. Mabel Vidal in the Department of Computer Science at the Un

Updated on:January 07,2024

Analysis calculates $725M in economic potential from expanded cancer treatment access

by Katja Wie, WifORRatio of cost of treatment to GDP per capita. Credit:The Lancet OncologyCommissionA recent analysis,publishedinThe Lancet Oncology, calculates that inc

Updated on: October 24,2024

Analysis calculates $725M in economic potential from expanded cancer treatment access

by Katja Wie, WifORRatio of cost of treatment to GDP per capita. Credit:The Lancet OncologyCommissionA recent analysis,publishedinThe Lancet Oncology, calculates that inc

Updated on:October 24,2024

New therapy could help chronic myeloid leukemia patients live drug-free

by South Australian Health and Medical Research Institute (SAHMRI)Credit: AI-generated imageThe latest research from SAHMRI and the University of Adelaide has discovered a potential new therapy for ch

Updated on: January 13,2024

New therapy could help chronic myeloid leukemia patients live drug-free

by South Australian Health and Medical Research Institute (SAHMRI)Credit: AI-generated imageThe latest research from SAHMRI and the University of Adelaide has discovered a potential new therapy for ch

Updated on:January 13,2024

Clinical trial: Less extensive breast cancer surgery results in fewer swollen arms

by Karolinska InstitutetCredit:New England Journal of Medicine(2024). DOI: 10.1056/NEJMoa2313487It is possible to leave most of the lymph nodes in the armpit, even if one or two of th

Updated on: April 06,2024

Clinical trial: Less extensive breast cancer surgery results in fewer swollen arms

by Karolinska InstitutetCredit:New England Journal of Medicine(2024). DOI: 10.1056/NEJMoa2313487It is possible to leave most of the lymph nodes in the armpit, even if one or two of th

Updated on:April 06,2024

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on: April 12,2024

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

Updated on:April 12,2024